Form 4: Indivior Pharmaceuticals Director Acquires RSUs

Daniel A. Ninivaggi, a Director at Indivior Pharmaceuticals, Inc., was granted 6,518 Restricted Stock Units (RSUs) on May 13, 2026.

Summary

• Daniel A. Ninivaggi, a Director of Indivior Pharmaceuticals, Inc., received a grant of 6,518 Restricted Stock Units (RSUs) on May 13, 2026.
• These RSUs represent a contingent right to receive one share of the company's common stock.
• The RSUs are scheduled to vest on the day before the annual stockholders' meeting following the grant date, contingent upon Mr. Ninivaggi's continued service to the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard equity grant for director compensation rather than a significant financial event or strategic shift.

Positives

• Director compensation through equity awards like RSUs can align management interests with shareholder value.
• The grant of RSUs indicates continued investment and commitment from a key company insider.

Risks

• The vesting of RSUs is contingent on continued service, meaning the director could forfeit the award if they leave the company before the vesting date.
• The value of the RSUs is tied to the future performance of Indivior Pharmaceuticals' stock price.

Future Outlook

The RSUs will vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the pharmaceutical industry to incentivize long-term performance and retention, aligning executive interests with those of shareholders.

Stakeholder Impact

• Shareholders: The alignment of director incentives with shareholder value through equity grants can be viewed positively.
• Employees: Standard compensation practices for directors can contribute to overall corporate governance stability.
• Management: The grant reinforces the director's ongoing role and commitment to the company.

Next Steps

• Vesting of RSUs on the day preceding the annual stockholders' meeting, subject to continued service.

Key Dates

Keywords

Indivior Pharmaceuticals, INDV, Form 4, Restricted Stock Units, RSUs, Director Compensation, Insider Transaction, Equity Grant